NASDAQ · USBC
Technology · Hardware, Equipment & Parts
$0.49
Up+$0.03 (+6.65%)
Updated Sep 12, 2026, 10:16 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
USBC closed at $0.49 after 20 trading sessions, up 27.65% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.4699 | $0.494 | $0.4609 | $0.4889 | 123.52K |
| Sep 10, 2026 | $0.48 | $0.48 | $0.4532 | $0.4584 | 179.03K |
| Sep 9, 2026 | $0.50 | $0.5147 | $0.4593 | $0.4593 | 770.25K |
| Sep 8, 2026 | $0.4944 | $0.5269 | $0.4796 | $0.5055 | 396.9K |
| Sep 4, 2026 | $0.50 | $0.50 | $0.4839 | $0.49 | 185.71K |
| Sep 3, 2026 | $0.4878 | $0.5135 | $0.4799 | $0.5009 | 509.06K |
| Sep 2, 2026 | $0.4806 | $0.49 | $0.4699 | $0.48 | 166.64K |
| Sep 1, 2026 | $0.4299 | $0.50 | $0.4299 | $0.479 | 1.25M |
| Aug 31, 2026 | $0.42 | $0.435 | $0.413 | $0.423 | 145.37K |
| Aug 28, 2026 | $0.4429 | $0.4598 | $0.417 | $0.4241 | 247.79K |
| Aug 27, 2026 | $0.405 | $0.454 | $0.405 | $0.4441 | 380.73K |
| Aug 26, 2026 | $0.4925 | $0.5178 | $0.40 | $0.4114 | 1.76M |
| Aug 25, 2026 | $0.4527 | $0.5178 | $0.4344 | $0.5178 | 1.43M |
| Aug 24, 2026 | $0.419 | $0.4675 | $0.396 | $0.4481 | 1.24M |
| Aug 21, 2026 | $0.438 | $0.4389 | $0.407 | $0.411 | 329.49K |
| Aug 20, 2026 | $0.41 | $0.4363 | $0.4065 | $0.4176 | 290.49K |
| Aug 19, 2026 | $0.40 | $0.4244 | $0.3783 | $0.403 | 452.31K |
| Aug 18, 2026 | $0.36 | $0.38 | $0.3538 | $0.3769 | 84.73K |
| Aug 17, 2026 | $0.39 | $0.39 | $0.351 | $0.367 | 79.75K |
| Aug 14, 2026 | $0.3579 | $0.3902 | $0.3512 | $0.383 | 264.77K |
The latest Smart Investors Daily articles mentioning USBC.
USBC research
Company profile and research snapshot.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Sep 1, 2026
Gainers Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday's after-market session. The company's market cap stands at $7.2 million. Jaguar Health (NASDAQ:JAGX) stock
Benzinga · Sep 1, 2026
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regular session. The company's market cap stands at $2.7 million. USBC (AMEX:USBC) stock moved upwards by 16.66% to
Benzinga · Aug 24, 2026
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001074828/000107482826000069/usbc-20260821.htm
Benzinga · Jun 17, 2026
USBC, Inc. (NYSE:USBC) ("USBC" or the "Company"), a publicly traded technology company that seeks to enable the transformation of traditional U.S. bank dollars into secure, compliant tokenized deposits, today announced
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning USBC.
